Clinical Data

Clinical research lies at the heart of who we are. Baxter uses scientific evidence systematically, and transparently, to inform the development of new and state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Baxter. 

A Focus on Clinical Research

HDx

Medium cut‑off dialyzer improves erythropoiesis stimulating agent resistance in a hepcidin‑independent manner in maintenance hemodialysis patients: results from a randomized controlled trial

View resource
HDx

Performance of medium cut-off dialyzers in expanded hemodialysis patients in Colombia

View resource
HDx

Pro-calcifying analysis of uraemic serum from patients treated with medium cut-off membrane in a prospective, cross-over study

View resource
HDx

Pruritus: Is there a grain of salty truth?

View resource
HDx

Randomized controlled trial of medium cut-off versus high-flux dialyzers on quality of life outcomes in maintenance hemodialysis patients.

View resource
HDx

Rationale for Medium Cutoff Membranes in COVID-19 Patients Requiring Renal Replacement Therapy

View resource
HDx

Removal of middle molecules with medium cutoff dialyzer in patients on short frequent hemodialysis

View resource
HDx

Can better efficacy of middle weight molecules removal in dialysis patients treated with medium cut-off membranes predict superiority over conventional high flux dialysers?

View resource
HDx

Chronic inflammation in end-stage renal disease and dialysis - Cobo G et al.

View resource
HDx

Effects of Expanded Hemodialysis Therapy on Clinical Outcomes - Mitra S et al.

View resource
HDx

Effects of Hemodialysis Therapy Using Dialyzers with Medium Cut-Off Membranes on Middle Molecules - Kirsch AH, et al.

View resource
HDx

Evaluation of the influence of the surface membrane and blood flow in medium «cut-off» (MCO) dialyzers - Maduell F et al.

View resource